HBIO - ハ―バ―ド・バイオサイエンス (Harvard Bioscience Inc.) ハ―バ―ド・バイオサイエンス

 HBIOのチャート


 HBIOの企業情報

symbol HBIO
会社名 Harvard Bioscience Inc. (ハ―バ―ド・バイオサイエンス)
分野(sector) Capital Goods   資本財(工業製品)
産業(industry) Biotechnology: Laboratory Analytical Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 ハーバード・バイオサイエンス(Harvard Bioscience Inc.)は世界中の医薬品・バイオ医薬品会社、大学及び政府研究所の生命科学研究を推進するための専門製品、装置及び科学機器の開発・製造・販売に従事するグローバル企業である。同社は850ページのカタログ(及び各種専門カタログ)、ウェブサイト及びGE Healthcare、Thermo Fisher Scientific Inc.とVWR等の流通業者を通じて、100カ国以上の数千人の研究者に製品を販売する。同社の製品は毒性(ADMET)試験及び分子生物学の2つの応用分野をターゲットにする。平成24年2月1日、同社は完全所有子会社Biochrom Ltd.を通してAHN Biotechnologie GmbHの事業を買収した。平成23年7月、同社はCMA Microdialysis AB.の前臨床事業を買収した。   ハ―バ―ド・バイオサイエンスは、米国の医療機器製造会社。製薬会社、バイオテクノ ロジ―会社、大学、政府の実験室など向けに、医薬品研究開発用器具の設計、製造、販売を行う。同社のプロテオミクス関連器具は、たんぱく質および薬剤候補のテストに用いられるADMET (吸収-分布 -代謝-排泄 -毒性) 解析の精製や分析に用いられる。本社は、マサチュ―セッツ州ホリストン。   Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
本社所在地 84 October Hill Road Holliston MA 01746 USA
代表者氏名 James W. Green ジェームズ・W・グリーン
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 508-893-8999
設立年月日 1901年
市場名 NASDAQ National Market System
ipoyear 2000年
従業員数 434人
url www.harvardbioscience.com
nasdaq_url https://www.nasdaq.com/symbol/hbio
adr_tso
EBITDA EBITDA(百万ドル) 4.39900
終値(lastsale) 4.61
時価総額(marketcap) 168631946.78
時価総額 時価総額(百万ドル) 156.92650
売上高 売上高(百万ドル) 110.79400
企業価値(EV) 企業価値(EV)(百万ドル) 212.75150
当期純利益 当期純利益(百万ドル) -4.24500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Harvard Bioscience Inc. revenues increased 57% to $58.3M. Net loss before extraordinary items increased from $1.4M to $7.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling/General/Admin. Expense increase of 73% to $11.7M (expense) Other expense net increase from $105K to $3.1M (expense).

 HBIOのテクニカル分析


 HBIOのニュース

   Preclinical Animal Behavior Market 2020-2028 how genes and environment come together to shape animal behavior| Harvard Bioscience, Columbus Instruments, Imetronic, Kinder Scientific, Med Associates  2020/10/22 09:00:25 OpenPR
Animal behavior includes all the ways animals interact with other members of their species, with organisms of other species, and with their environment. Both external and internal stimuli prompt behaviors external information (e.g., threats from other animals, sounds, smells) or
   Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET  2020/07/20 12:30:00 GlobeNewswire
HOLLISTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended…
   Harvard Bioscience (HBIO) Reports Q1 Loss, Lags Revenue Estimates  2020/05/05 13:15:14 Zacks Investment Research
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -125.00% and -15.10%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Harvard Bioscience (HBIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release  2020/04/28 16:33:21 Zacks Investment Research
Harvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection  2020/03/19 11:37:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
   Preclinical Animal Behavior Market 2020-2028 how genes and environment come together to shape animal behavior| Harvard Bioscience, Columbus Instruments, Imetronic, Kinder Scientific, Med Associates  2020/10/22 09:00:25 OpenPR
Animal behavior includes all the ways animals interact with other members of their species, with organisms of other species, and with their environment. Both external and internal stimuli prompt behaviors external information (e.g., threats from other animals, sounds, smells) or
   Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET  2020/07/20 12:30:00 GlobeNewswire
HOLLISTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended…
   Harvard Bioscience (HBIO) Reports Q1 Loss, Lags Revenue Estimates  2020/05/05 13:15:14 Zacks Investment Research
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -125.00% and -15.10%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Harvard Bioscience (HBIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release  2020/04/28 16:33:21 Zacks Investment Research
Harvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection  2020/03/19 11:37:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
   Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET  2020/07/20 12:30:00 GlobeNewswire
HOLLISTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended…
   Harvard Bioscience (HBIO) Reports Q1 Loss, Lags Revenue Estimates  2020/05/05 13:15:14 Zacks Investment Research
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -125.00% and -15.10%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Harvard Bioscience (HBIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release  2020/04/28 16:33:21 Zacks Investment Research
Harvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection  2020/03/19 11:37:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
   Harvard Bioscience (HBIO) Matches Q3 Earnings Estimates  2019/11/05 23:15:09 Zacks Investment Research
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 0.00% and -3.80%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

 関連キーワード  (先端医療機器_テクノロジ― 米国株 ハ―バ―ド・バイオサイエンス HBIO Harvard Bioscience Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)